The immunosuppressant Ilaris is prescribed for the following diseases:
– acute gouty arthritis:
– treatment of frequent acute attacks of gouty arthritis and prevention of the development of new attacks.
– Cryopyrin-associated periodic syndrome in adults and children aged ≥2 years, including:
– familial cold autoinflammatory syndrome/familial cold urticaria;
– Muckle-Wales syndrome;
– infantile multisystem inflammatory disease/chronic infantile neurological cutaneous-articular syndrome;
– active phase of systemic juvenile idiopathic arthritis in children aged ≥2 years.
Active ingredient: canakinumab
Storage temperature: 2-8 degrees
Prescription medicine